Brent Neuschwander-Tetri, MD
Gastroenterology · Saint Louis, MONPI 1699783563
Payments from drug & device makers
Across 315 payments — averaging $2315.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$185K
- E.r. Squibb & Sons, L.L.C.$178K
- Intercept Pharmaceuticals, Inc.$122K
- Gilead$83K
- Intercept Pharma Europe Ltd.$45K
- AbbVie$38K
- plus $79K from 18 others
Across 1 payment — averaging $77.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$78
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 73 | $185,068 |
| E.r. Squibb & Sons, L.L.C. | 19 | $177,926 |
| Intercept Pharmaceuticals, Inc. | 55 | $121,774 |
| Gilead | 60 | $82,565 |
| Intercept Pharma Europe Ltd. | 3 | $44,833 |
| AbbVie(2 entities) | 38 | $38,345 |
| Merck | 28 | $24,881 |
| Bristol Myers Squibb | 4 | $24,539 |
| Boehringer Ingelheim | 9 | $6,821 |
| Siemens Medical Solutions USA, Inc. | 6 | $5,739 |
| Novo Nordisk AS | 1 | $4,875 |
| GSK | 2 | $4,001 |
| Amgen | 1 | $2,616 |
| Theratechnologies Inc. | 1 | $2,000 |
| AstraZeneca | 2 | $1,600 |
| Pfizer | 2 | $1,000 |
| Mirum Pharmaceuticals, Inc. | 2 | $245 |
| Novo Nordisk | 2 | $188 |
| Ipsen Biopharmaceuticals, Inc | 1 | $131 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| Ferring International Pharmascience Center US | 1 | $26 |
| Abbott | 1 | $22 |
| Conmed Corporation | 1 | $21 |
| Dova Pharmaceuticals | 1 | $13 |
How this compares
$729,276 in reported general payments places this provider in the 95th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Saint Louis
- Parakkal DeepakSaint Louis$2M
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$920K
- Kevin KorenblatSaint Louis$857K
- David AlpersSaint Louis$616K
- Chandra GyawaliSaint Louis$593K
- Richard RoodSaint Louis$567K
- Matthew CiorbaSaint Louis$551K
- Bruce BaconSaint Louis$307K
- Wing-Kin SynSaint Louis$283K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.